Wedbush Reiterates Outperform on IDEAYA Biosciences, Maintains $52 Price Target
IDEAYA Biosciences
IDEAYA Biosciences IDYA | 0.00 |
Wedbush analyst Robert Driscoll reiterates IDEAYA Biosciences (NASDAQ:
IDYA) with a Outperform and maintains $52 price target.
